The study won't be studying any new medications or therapy. But if it turns out to be a success, this could be great news for the platform and for Apple, and could lead to employing ResearchKit in other clinical trials that study the effectiveness of new drugs and treatments. At the same time though, certain factors still need to be worked out. As Bloomberg points out, the use of ResearchKit relies on the fact that participants have an Apple device, which can be expensive. And while some research groups provide an Apple device to borrow for the study, this exclusion in general could lead to the research representing some demographics more than others.